Intertek Expands GLP Bioanalytical Centre of Excellence In San Diego, California
10/21/2015
According to company officials, its expansion in capacity and new technology of the San Diego facility, which spans 46,000 square feet of laboratories, offices and sample storage, will benefit customers involved in preclinical and clinical development of small molecule drugs and biologic medicines. Investment in new bioanalytical technologies further strengthens capabilities to expedite delivery of fast and cost-effective bioanalysis results for global clients.
Mark Hammond, Intertek Pharmaceutical Services Business Leader said, “Our expanded GLP Bioanalytical Centre of Excellence in San Diego and new technologies provide a broader range of bioanalytical, biomarker, and cell-based capabilities services to meet our clients’ needs in preclinical and clinical bioanalysis, helping them to understand the safety, efficacy and mechanism of action of their small and large molecule drugs in development.”
Chetan Parmar, Senior Vice President of Intertek Life Sciences, said, “With recent expansion in bioanalytical capabilities in both the US and Europe, we further strengthen our capability to address the challenges our clients encounter during drug development through delivery of excellent global bioanalytical services."
The facility offers new technologies such as flow cytometry which will provide clients with robust and comprehensive analysis of cells to help understand the mechanism of action of drugs and facilitate evaluation of drug stability and potency. Furthermore, flow cytometry opens up an additional platform for assessing cell based neutralizing antibody activity in clinical trials, which is important in assessing any potential adverse immunological effects.
Luminex, another new technology at this site, will build on current high throughput and multiplexing capabilities to allow customised measurement of up to 100 analytes simultaneously using very small volumes of sample, officials said. This is ideal for studies where there is limited sample volume. Additional investment in new state-of-the-art liquid chromatography- mass spectrometry instruments not only upgrade Intertek's small molecule bioanalysis capabilities but also improve sensitivity and mass range for analysis of protein therapeutics.
Project Announcements
Loc Performance Products Upgrades St. Marys, Ohio, Facility
06/30/2022
Lockheed Martin Plans Huntsville, Alabama, Missile System Integration Lab
06/30/2022
EAB Consolidates-Expands Henrico County, Virginia, Operations
06/30/2022
Germany-Based Papier-Mettler Plans Moorefield, West Virginia, Operations
06/29/2022
Fair Oaks Foods Plans Davenport, Iowa, Production Facility
06/29/2022
Hyundai Motor America Plans Superior Township, Michigan, Safety Test and Investigation Laboratory
06/28/2022
Most Read
-
Area Development’s 17th Annual Shovel Awards Recognize State and Local Economic Development Efforts — First Two Platinum Shovels Awarded
Q2 2022
-
The 2021 Top States for Doing Business Reflect Their Locational Advantages
Q3 2021
-
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Q1 2022
-
The Evolution of the Megasite
Q2 2022
-
Five Ways for Manufacturers to Manage Global Market Volatility
Q2 2022
-
In Focus: Demand for Industrial Land Surges
Q2 2022
-
Putting Your Best Foot Forward: Presentation of Incentives Information to the Media
Q2 2022